blog
TSO and MS: Phase 1 Clincal Trial Complete
The Phase 1 clinical trial of TSO for treatment of Multiple Sclerosis, conducted by Dr.Fleming at the University of Wisconsin School of Medicine and Public Health, is now complete. No adverse effects in the 5 patients, and a reduction of MRI-measured brain leasions in all 5. The abstract
Article on TSO and my son in The Scientist
The story of my son and our experience with TSO is chronicled in an article in the February, 2001 issue of The Scientist. The author provides a lot of background information on the Hygiene Hypothesis and the work of Doctors Weinstock, Elliott and Summers on Crohn’s Disease and Ulcerative
Textbook chapter on my experience with TSO
I have authored a chapter describing my experience with TSO in Textbook of Autism Spectrum Disorders, published by APPI. The chapter is titled “An Experimental Treatment for Autism“‘. (Note: I received no compensation for this, nor do I receive any compensation from sales of the textbook)
Scientists uncover a mechanism of action in helminth therapy
IL-22 CD4 T Cells are involved in therapeutic T. trichuria infection in Ulcerative Colitis. Sci Transl Med 2010: Dec 1;2(60):60ra88
OCD Immune link
OCD behavior in mice has been linked to the Hoxb8 gene. Hoxb8 is found in microglia, immune cells that guard against pathogens. This study was reported in Science Now. A podcast interview with the Nobel Laureate that did the study plus a link to the actual published article appear in the
Your are viewing Page 1 of 5 for the blog